We must eliminate discrimination and bias in healthcare, and I will continue to advocate for community-driven solutions to the racial health disparity crisis.
I will continue to advocate for community-driven solutions to the racial health disparity crisis.
Occurrences
I am glad that the Biden-Harris Administration is prioritizing health equity and will continue to work for equitable distribution of COVID relief.
Evidence
The campaign page said Brown would support equitable health care and, on maternal and infant mortality, would "continue to support community-based solutions to this crisis." It framed her approach as working with the Biden-Harris administration on health equity and ending discrimination and bias in health care.
Brown’s official House issue page states she co-led a letter urging the FDA to investigate the health risks of chemical hair straighteners marketed to Black women and adds that she "will continue to advocate for community-driven solutions to the racial health disparity crisis."
Brown announced the U-FIGHT Act, which would authorize HHS grants for early detection, intervention, education, awareness, and research on uterine fibroids. The release says fibroids disproportionately impact Black women and that Brown introduced the bill to address that disparity.
Congress.gov lists Rep. Brown as sponsor of H.R. 4392, introduced July 15, 2025, with the official purpose to authorize HHS grants to increase early detection of and intervention for uterine fibroids. The latest action shown is referral to the House Committee on Energy and Commerce.
Cuyahoga County said the council passed legislation declaring racism a public health crisis. The county article quotes then-Councilwoman Shontel Brown saying the resolution was a first step and that the hard work was to change policies and procedures.
Assessments
The promise was to continue advocating for community-driven solutions to racial health disparities, not necessarily to enact a specific law. Evidence shows Brown maintained official public advocacy on racial health disparities, co-led FDA oversight related to products marketed to Black women, and introduced the U-FIGHT Act to address uterine fibroids, a condition disproportionately affecting Black women. Although the bill did not advance beyond referral, the promised outcome was continued advocacy, which was met during the same term.